BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND FIP1L1, DKFZp586K0717, 81608, ENSG00000145216, Q6UN15
191 results:

  • 1. Treatment patterns, clinical outcomes and gene mutation characteristics of hepatitis B virus-associated mantle cell lymphoma.
    Feng J; Fei Y; Gao M; Meng X; Zeng D; Zou D; Ye H; Liang Y; Sun X; Liang R; Zhou H; Wang X; Zhang H
    Hematol Oncol; 2024 May; 42(3):e3268. PubMed ID: 38676394
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Integration of Genomic Sequencing Drives Therapeutic Targeting of PDGFRA in T-Cell Acute Lymphoblastic leukemia/Lymphoblastic Lymphoma.
    Paolino J; Dimitrov B; Apsel Winger B; Sandoval-Perez A; Rangarajan AV; Ocasio-Martinez N; Tsai HK; Li Y; Robichaud AL; Khalid D; Hatton C; Gillani R; Polonen P; Dilig A; Gotti G; Kavanagh J; Adhav AA; Gow S; Tsai J; Li Y; Ebert BL; Van Allen EM; Bledsoe J; Kim AS; Tasian SK; Cooper SL; Cooper TM; Hijiya N; Sulis ML; Shukla NN; Magee JA; Mullighan CG; Burke MJ; Luskin MR; Mar BG; Jacobson MP; Harris MH; Stegmaier K; Place AE; Pikman Y
    Clin Cancer Res; 2023 Nov; 29(22):4613-4626. PubMed ID: 37725576
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Myeloid/lymphoid neoplasms with eosinophilia and tyrosine kinase gene fusions: reevaluation of the defining characteristics in a registry-based cohort.
    Metzgeroth G; Steiner L; Naumann N; Lübke J; Kreil S; Fabarius A; Haferlach C; Haferlach T; Hofmann WK; Cross NCP; Schwaab J; Reiter A
    Leukemia; 2023 Sep; 37(9):1860-1867. PubMed ID: 37454239
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. [fip1l1::PDGFRA-positive chronic eosinophilic leukemia showing slowly progressive cardiac impairment].
    Shimizu M; Kuroda A; Suyama T; Seki M; Shinagawa A
    Rinsho Ketsueki; 2022; 63(12):1648-1652. PubMed ID: 36653138
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. fip1l1-PDGFRA fusion gene in T-lymphoblastic lymphoma: A case report.
    Ali S; Al-Qattan Y; Awny W; Hamadah A; Pinto K; AlShemmari S
    Cancer Rep (Hoboken); 2023 Jan; 6(1):e1769. PubMed ID: 36517458
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. [fip1l1::PDGFRA-positive chronic eosinophilic leukemia presenting with multiple ulcers of oral cavity and gastrointestinal tract].
    Nagamatsu K; Yanai Y; Gamachi A; Ono K
    Rinsho Ketsueki; 2022; 63(11):1503-1507. PubMed ID: 36476788
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Two pediatric oncologic cases of hypereosinophilic syndrome and review of the literature.
    Voeller J; DeNapoli T; Griffin TC
    Cancer Rep (Hoboken); 2022 Nov; 5(11):e1710. PubMed ID: 36241191
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Fusion Gene Detection and Quantification by Asymmetric Capture Sequencing (aCAP-Seq).
    Gricourt G; Tran Quang V; Cayuela JM; Boudali E; Tarfi S; Barathon Q; Daveau R; Joy C; Wagner-Ballon O; Bories D; Pautas C; Maury S; Rea D; Roy L; Sloma I
    J Mol Diagn; 2022 Nov; 24(11):1113-1127. PubMed ID: 35963522
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. EAHP 2020 workshop proceedings, pediatric myeloid neoplasms.
    Leguit RJ; Orazi A; Kucine N; Kvasnicka HM; Gianelli U; Arber DA; Porwit A; Ponzoni M
    Virchows Arch; 2022 Oct; 481(4):621-646. PubMed ID: 35819517
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Lab tests for MPN.
    Moncada A; Pancrazzi A
    Int Rev Cell Mol Biol; 2022; 366():187-220. PubMed ID: 35153004
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. [Emergence of mutation in the colony-stimulating factor 3 receptor gene during follow-up of unclassifiable myeloproliferative neoplasm].
    Harada S; Okada K; Yokoyama S; Hidaka D; Hayase E; Onozawa M; Goto H; Hashimoto D; Kahata K; Endo T; Teshima T
    Rinsho Ketsueki; 2021; 62(11):1609-1614. PubMed ID: 34866084
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Utilizing next-generation sequencing to characterize a case of acute myeloid leukemia with t(4;12)(q12;p13) in the absence of ETV6/CHIC2 and ETV6/PDGFRA gene fusions.
    Koleilat A; McGarrah PW; Olteanu H; Van Dyke DL; Smadbeck JB; Johnson SH; Vasmatzis G; Hoppman NL; Xu X; Ketterling RP; Greipp PT; Baughn LB; Patnaik MS; Peterson JF
    Cancer Genet; 2022 Jan; 260-261():1-5. PubMed ID: 34781094
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Successful treatment and integrated genomic analysis of an infant with fip1l1-RARA fusion-associated myeloid neoplasm.
    Miltiadous O; Petrova-Drus K; Kaicker S; Mathew S; Kluk M; Geyer JT; Rodriguez-Sanchez I; Bouvier N; Inghirami G; Stieglitz E; Khedoudja N; Benayed R; Richardson M; Anderson W; Benhamida J; You D; Londono D; Kung AL; Prockop SE; Roshal M; Zhang Y; Shukla N
    Blood Adv; 2022 Feb; 6(4):1137-1142. PubMed ID: 34551074
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Alternative polyadenylation dysregulation contributes to the differentiation block of acute myeloid leukemia.
    Davis AG; Johnson DT; Zheng D; Wang R; Jayne ND; Liu M; Shin J; Wang L; Stoner SA; Zhou JH; Ball ED; Tian B; Zhang DE
    Blood; 2022 Jan; 139(3):424-438. PubMed ID: 34482400
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. fip1l1-PDGFRA-Associated Hypereosinophilic Syndrome as a Treatable Cause of Watershed Infarction.
    Tennenbaum J; Groh M; Venditti L; Campos-Gazeau F; Chalayer E; De Broucker T; Hamidou M; Hunault M; Lyoubi A; Meunier R; Muron T; Sène D; Slama B; Guidoux C; Lefèvre G; Kahn JE; Denier C; Rohmer J
    Stroke; 2021 Oct; 52(10):e605-e609. PubMed ID: 34304603
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Eosinophils and eosinophil-associated disorders: immunological, clinical, and molecular complexity.
    Valent P; Degenfeld-Schonburg L; Sadovnik I; Horny HP; Arock M; Simon HU; Reiter A; Bochner BS
    Semin Immunopathol; 2021 Jun; 43(3):423-438. PubMed ID: 34052871
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Venous thrombosis and predictors of relapse in eosinophil-related diseases.
    Réau V; Vallée A; Terrier B; Plessier A; Abisror N; Ackermann F; Benainous R; Bohelay G; Chabi-Charvillat ML; Cornec D; Desbois AC; Faguer S; Freymond N; Gaillet A; Hamidou M; Killian M; Le Jeune S; Marchetti A; Meyer G; Osorio-Perez F; Panel K; Rautou PE; Rohmer J; Simon N; Tcherakian C; Vasse M; Zuelgaray E; Lefevre G; Kahn JE; Groh M
    Sci Rep; 2021 Mar; 11(1):6388. PubMed ID: 33737704
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Aberrant expression of NKL homeobox genes HMX2 and HMX3 interferes with cell differentiation in acute myeloid leukemia.
    Nagel S; Pommerenke C; Meyer C; MacLeod RAF; Drexler HG
    PLoS One; 2020; 15(10):e0240120. PubMed ID: 33048949
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. S100A8 and S100A9 Promote Apoptosis of Chronic Eosinophilic leukemia Cells.
    Lee JS; Lee NR; Kashif A; Yang SJ; Nam AR; Song IC; Gong SJ; Hong MH; Kim G; Seok PR; Lee MS; Sung KH; Kim IS
    Front Immunol; 2020; 11():1258. PubMed ID: 32903598
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Genotypic and Phenotypic Characteristics of Acute Promyelocytic leukemia Translocation Variants.
    Mannan A; Muhsen IN; Barragán E; Sanz MA; Mohty M; Hashmi SK; Aljurf M
    Hematol Oncol Stem Cell Ther; 2020 Dec; 13(4):189-201. PubMed ID: 32473106
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 10.